Company intelligence / Profile preview

Trillion Genomics

Ickleton/Cambridge, Cambridgeshire, United Kingdomfind-and-update.company-information.service.gov.uk ↗

Ownership: Private
Development stage: Preclinical

Overview

Trillion Genomics has developed a mass spectrometry technique aimed at revolutionizing cancer prevention, diagnosis, and therapy. The company also holds patents related to oligonucleotides capable of discriminating between closely related nucleic acid sequences. There are no public clinical trial results or therapeutic products reported.

Therapeutic areas: Oncology
Modalities: Mass spectrometry-based diagnosticsOligonucleotide technology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Trillion Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trillion Genomics.

Explore the full profile